Search Results 801-810 of 16991 for pharmacogenetics

  1. Clinical trials - Oncology (Medical)

    Cohort C: Triple-negative breast cancer (TNBC);; Cohort D: Platinum-resistant/refractory epithelial ovarian, primary peritoneal, or fallopian tube cancer ( ...

  2. Phase 2 Study to Evaluate the Oral Combination of Ixazomib (MLN9708) With Cyclophosphamide and Dexamethasone in Patients With Newly Diagnosed or Relapsed and/or Refractory Multiple Myeloma - Mayo Clinic

    About this study. This is a phase 2, multicenter, open-label study in patients with Newly Diagnosed Multiple Myeloma (NDMM) who have not received prior ...

  3. Standardized Measure of Premenstrual Symptoms Among Transgender Men and Gender-Diverse Adults - Mayo Clinic

    The purpose of this study is to obtain preliminary quantitative and qualitative data on the validity of the Premenstrual Symptoms Screening Tool (PSST) in TGD ...

  4. Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01) - Mayo Clinic

    The purpose of this study is to assess the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary effectiveness of JANX007 ...

  5. A Study to Evaluate Quality of Life Over Time in Patients Treated with CAR-T Cell Therapy Compared with Stem Cell Transplantation in Hematologic Malignancies - Mayo Clinic

    The purpose of this study is to evaluate quality of life over time in patients treated with CAR-T therapy compared with autologous and allogeneic stem cell ...

  6. Innovative Trial for Understanding the Impact of Targeted Therapies in NF2 - Mayo Clinic

    The purpose of this study is to test multiple experimental therapies simultaneously in patients with neurofibromatosis type 2 (NF2) with associated progressive ...

  7. Medical Research & Education - Mayo Clinic News Network

    As scientists at the Mayo Clinic Center for Individualized Medicine discover new ways to use genomic information in the diagnosis, treatment and prevention of ...

  8. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

    The objective of this study is to evaluate the efficacy and safety of upadacitinib compared to placebo as induction therapy in participants with moderately and ...

  9. Clinical trials - Oncology (Medical)

    Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by ...

  10. A Study to Assess Feasibility and Benefit of a Patient-reported Outcomes Quality of Life Tool for Hematology and Medical Oncology - Mayo Clinic

    The purpose of this study is to determine the feasibility and benefit of a patient-reported outcomes quality of life tool for hematology and medical oncology.